Antares pharma reports third quarter 2019 operating and financial results

Antares pharma reports third quarter 2019 operating and financial results.q3 earnings per share $0.01.q3 revenue rose 92 percent to $34.3 million.q3 revenue estimate $26.9 million -- refinitiv ibes data.q3 earnings per share estimate $-0.02 -- refinitiv ibes data.sees fy 2019 revenue $115 million to $120 million.at september 30, 2019, cash and cash equivalents were $41.9 million compared to $27.9 million at december 31, 2018.fy2019 revenue view $108.3 million -- refinitiv ibes data.
ATRS Ratings Summary
ATRS Quant Ranking